Described herein are pharmaceutical packaging units which stop oxidative degradation of morphine, hydromorphone, promethazine and also other oxygen-sensitive drugs, these programs such as a syringe having an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with very very low permeability to oxygen and comprises ethyl